These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis? McDonald S; Reed R; Baricevic-Jones I; ; Ling S; Plant D; Barton A Rheumatology (Oxford); 2019 Oct; 58(10):1872-1873. PubMed ID: 31329971 [No Abstract] [Full Text] [Related]
5. Targeting interleukin-33 in rheumatoid arthritis. Rong C; Hu W; Wu FR; Chen FH Rheumatol Int; 2013 May; 33(5):1377-8. PubMed ID: 22210269 [No Abstract] [Full Text] [Related]
6. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104 [TBL] [Abstract][Full Text] [Related]
7. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Lee SY; Yoon BY; Kim JI; Heo YM; Woo YJ; Park SH; Kim HY; Kim SI; Cho ML Immunology; 2014 Mar; 141(3):353-61. PubMed ID: 24708416 [TBL] [Abstract][Full Text] [Related]
10. [Adhesion molecule in pathogenesis of rheumatoid arthritis]. Origuchi T; Eguchi K Nihon Rinsho; 2005 Jan; 63 Suppl 1():200-7. PubMed ID: 15799346 [No Abstract] [Full Text] [Related]
11. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis. Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439 [TBL] [Abstract][Full Text] [Related]
12. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response. Matsuyama Y; Okazaki H; Hoshino M; Onishi S; Kamata Y; Nagatani K; Nagashima T; Iwamoto M; Yoshio T; Ohto-Ozaki H; Tamemoto H; Komine M; Sekiya H; Tominaga S; Minota S Rheumatol Int; 2012 May; 32(5):1397-401. PubMed ID: 21431944 [TBL] [Abstract][Full Text] [Related]
13. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis]. Hammer HB Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899 [No Abstract] [Full Text] [Related]
14. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 2014 Dec; 56(1458):127-32. PubMed ID: 25519024 [No Abstract] [Full Text] [Related]